HMGB2 in endocrine resistant breast cancer

ABSTRACT: HMGB2 and ER ChIPseq was investigated in the MCF-7 endocrine sensitive and LY2 endocrine resistant cell lines upon treatment with Tamoxifen.

INSTRUMENT(S): Illumina Genome Analyzer II

ORGANISM(S): Homo sapiens

SUBMITTER: Gordon Brown 

PROVIDER: E-MTAB-1865 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress